InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: Whalatane post# 304884

Wednesday, 10/14/2020 5:37:57 AM

Wednesday, October 14, 2020 5:37:57 AM

Post# of 425931
Kiwi...the possibility of the Marjac Amicus taking hold with CAFC was only a little over zero- and basing investment decision on its rejection/acceptance is rather questionable -the en banc is probably a little higher as to prospect but no one should hold their breath on that ... there remain other opportunities to litigate and Amarin will take them .... delay and litigate delay and litigate ...the generics are in a difficult place following Teva case- it’s no slam dunk that they can rush into ... they may just decide it ain’t worth The risk Europe is a big and long lasting market ahead.... ROW also -there maybe interest in time to come to acquire the company from those better placed to obtain best value
I agree Amarin is not a sexy quick fire option - there are no doubt other more attractive ones ... but for those in it and in no rush 5 dollars sp will be significantly bettered over time
Amarin has worked through some very tough territory previously - the company must work super hard to improve its performance and communication - I guess they have been a little punch drunk but I remain optimistic they will keep this fight going and battle through
Why ? This drug is simply one of the best ground breaking developments in medicine -we must never loose sight of that ...it’s benefits are yet to be fully utilised and fully appreciated

Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News